Volume 12, Issue 4 pp. 371-373

The use of methohexital during neonatal cardioversion

K. ALLEGAERT MD

K. ALLEGAERT MD

Neonatal Intensive Care Unit, Department of Paediatrics, University Hospitals, Gasthuisberg, Leuven, Belgium,

Search for more papers by this author
G. NAULAERS MD

G. NAULAERS MD

Neonatal Intensive Care Unit, Department of Paediatrics, University Hospitals, Gasthuisberg, Leuven, Belgium,

Search for more papers by this author
M. GEWILLIG MD, PhD

M. GEWILLIG MD, PhD

Paediatric Cardiology, Department of Paediatrics, University Hospitals, Gasthuisberg, Leuven, Belgium

Search for more papers by this author
H. DEVLIEGER MD, PhD

H. DEVLIEGER MD, PhD

Neonatal Intensive Care Unit, Department of Paediatrics, University Hospitals, Gasthuisberg, Leuven, Belgium,

Search for more papers by this author
First published: 01 May 2002
Citations: 3
K. Allegaert Neonatal Intensive Care Unit, Department of Paediatrics, University Hospitals, Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium (e-mail: [email protected]).

Abstract

We report on the use of methohexital during elective neonatal direct current cardioversion. In contrast with the available data on cardiac management in neonates with supraventricular tachycardia and the guidelines on anaesthetic management during cardioversion in adults, data on anaesthetic management in neonates are still lacking. Methohexital might be an option for procedural sedation and anaesthesia during elective cardioversion in neonates.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.